A transient inhibition of DNA repair using potent PARP1 inhibitors could improve the efficacy of cancer treatments, in fact, PARP1 inhibition is considered as a useful therapeutic strategy for the treatment of a wide range of tumours. Here, PARP1 is linked to cancer.